KRT8 and cancer: We next used the CRISPR-Cas9 technique to delete a 2.56-kb enhancer fragment in the KRT8 intron region that contains rs55958994 in 22Rv1 cells; 22Rv1 cells are a diploid cancer cell line and thus are a good model for the creation of homozygous deletions (fig.